Skip to main content
logo
Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia flag Australia · Delayed Price · Currency is AUD
0.2420
-0.0430 (-15.09%)
Sep 11, 2026, 12:42 PM AEST

ASX:PAR Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
1719611989279224
Market Cap Growth
59.50%-18.75%32.94%-67.97%24.43%-53.57%
Enterprise Value
163919456195170
Last Close Price
0.280.170.300.260.960.93

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-14.0514.0514.05--
PS Ratio
-----2829.64
PB Ratio
49.2027.805.613.605.205.30
P/TBV Ratio
66.5837.625.724.095.505.70

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
-----2142.53

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
2.162.1600.010.010.02
Net Debt / Equity Ratio
-2.29-2.29-0.79-0.71-1.04-0.92
Net Debt / EBITDA Ratio
0.130.130.730.270.940.82
Net Debt / FCF Ratio
0.180.181.050.271.241.21
Asset Turnover
-----0.00
Quick Ratio
1.071.077.177.124.855.93
Current Ratio
1.101.107.467.514.896.02
Return on Equity (ROE)
-456.96%-456.96%-81.66%-149.69%-108.16%-65.10%
Return on Assets (ROA)
-138.75%-138.75%-55.11%-85.28%-63.78%-44.22%
Return on Capital Employed (ROCE)
-1540.60%-1540.60%-109.40%-260.30%-111.20%-111.80%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-32.99%-58.38%-15.80%-65.74%-18.61%-17.51%
FCF Yield
-25.58%-45.27%-13.46%-73.81%-16.20%-14.37%
Buyback Yield / Dilution
-17.66%-17.66%-7.23%-17.43%-7.34%-1.21%